TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 29049902

Group type: EXPERIMENTAL
Intervention: Concurrent Treatment with Prolonged Exposure (COPE)
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Relapse Prevention Therapy (RPT)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Active Monitoring Control Group (AMCG)
Number of subjects: 110
Study: 26769459

Group type: EXPERIMENTAL
Intervention: Rasagiline 1 mg daily for 12 weeks
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo for 12 weeks
Number of subjects: 30
Study: 23442834

Group type: EXPERIMENTAL
Intervention: Peginterferon alpha‐2a (40 kDa) plus ribavirin for 72 weeks
Number of subjects: 942

Group type: COMPARATOR
Intervention: Peginterferon alpha‐2a (40 kDa) plus ribavirin for 48 weeks
Number of subjects: 942

Group type: EXPERIMENTAL
Intervention: 72 weeks of treatment
Number of subjects: 942

Group type: COMPARATOR
Intervention: 48 weeks of treatment
Number of subjects: 942

Group type: EXPERIMENTAL
Intervention: Stopping treatment at week 12 for non-cEVR patients
Number of subjects: 942

Group type: EXPERIMENTAL
Intervention: Stopping treatment at week 12 for cEVR patients
Number of subjects: 942
Study: 22168328

Group type: EXPERIMENTAL
Intervention: Multimodal weight-reduction program
Number of subjects: 54
Study: 18647396

Group type: COMPARATOR
Intervention: Remote therapy (telephone, internet, videoconference)
Number of subjects: 894
Study: 16834839

Group type: EXPERIMENTAL
Intervention: Epoetin alfa 80 000 U every 2 weeks (Q2W)
Number of subjects: 310

Group type: COMPARATOR
Intervention: Epoetin alfa 40 000 U weekly (QW)
Number of subjects: 310
Study: 15017641

Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 100

Group type: COMPARATOR
Intervention: Midazolam plus fentanyl
Number of subjects: 100
Study: 10693734

Group type: EXPERIMENTAL
Intervention: 60 mg of orlistat TID
Number of subjects: 796

Group type: EXPERIMENTAL
Intervention: 120 mg of orlistat TID
Number of subjects: 796

Group type: COMPARATOR
Intervention: Placebo TID
Number of subjects: 796
Study: 9490144

Group type: EXPERIMENTAL
Intervention: Leuprolide 3.75 mg LP
Number of subjects: 68

Group type: COMPARATOR
Intervention: Triptorelin 3.75 mg LP
Number of subjects: 68
Study: 8353106

Group type: EXPERIMENTAL
Intervention: Consulting skills training programme
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (students not trained in consulting skills)
Number of subjects: 0
Study: 3754233

Group type: EXPERIMENTAL
Intervention: Cimetidine 400 mg bd + Pirenzepine 50 mg bd
Number of subjects: 8

Group type: COMPARATOR
Intervention: Cimetidine 400 mg bd
Number of subjects: 8

Group type: COMPARATOR
Intervention: Pirenzepine 50 mg bd
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Cimetidine 200 mg bd + Pirenzepine 25 mg bd
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 29562613

Group type: EXPERIMENTAL
Intervention: Low Glycemic Index Diet (LGI)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Moderate Glycemic Index Diet (MGI)
Number of subjects: 21
Study: 27342387

Group type: EXPERIMENTAL
Intervention: Therapeutic dose of tedizolid phosphate (200mg)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Supratherapeutic dose of tedizolid phosphate (1200mg)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Moxifloxacin (positive control)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo (negative control)
Number of subjects: 48
Study: 23591951

Group type: EXPERIMENTAL
Intervention: Parallel squat with 80% 1 repetition maximum without vibration (NV‐PS)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Parallel squat with 80% 1 repetition maximum on a whole body vibration platform (WBV‐PS)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Control (C)
Number of subjects: 15
Study: 22429308

Group type: EXPERIMENTAL
Intervention: Web-based health risk assessment with individually-tailored feedback
Number of subjects: 0

Group type: COMPARATOR
Intervention: Waiting list control group
Number of subjects: 0
Study: 20019625

Group type: EXPERIMENTAL
Intervention: Elastic bands
Number of subjects: 50

Group type: COMPARATOR
Intervention: Weights
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo control
Number of subjects: 50
Study: 18682410

Group type: EXPERIMENTAL
Intervention: 5 ml ropivacaine 0.5%
Number of subjects: 40

Group type: COMPARATOR
Intervention: 20 ml ropivacaine 0.5%
Number of subjects: 40
Study: 15591298

Group type: EXPERIMENTAL
Intervention: HRT users
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Fit groups
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: HRT users and fit groups
Number of subjects: 48

Group type: COMPARATOR
Intervention: All groups
Number of subjects: 48

Group type: COMPARATOR
Intervention: Physically fit women
Number of subjects: 48

Group type: COMPARATOR
Intervention: Fitness
Number of subjects: 48
Study: 12616317

Group type: EXPERIMENTAL
Intervention: Single-segment algorithm (tau = 250 ms)
Number of subjects: 104

Group type: COMPARATOR
Intervention: 2-segment fixed end algorithm (tau = 125-250 ms)
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: 2-segment fixed start algorithm (tau = 105-210 ms)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Single-segment algorithm (tau = 210 ms)
Number of subjects: 104
Study: 12516414

Group type: EXPERIMENTAL
Intervention: Indomethacin 25 mg three times a day for 7 days with tegafur 200 mg three times a day (Group I, n = 11)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Tegafur 200 mg three times a day without indomethacin (Group II, n = 10)
Number of subjects: 21
Study: 9098853

Group type: EXPERIMENTAL
Intervention: Allopurinol (10 mg/kg after meeting criteria and before cannulation, plus a 20 mg/kg priming dose to the ECMO circuit)
Number of subjects: 25
Study: 8210924

Group type: EXPERIMENTAL
Intervention: Etodolac (300 mg b.i.d.)
Number of subjects: 1289

Group type: COMPARATOR
Intervention: Active-reference preparations (including piroxicam, naproxen, indomethacin, indomethacin SR, diclofenac SR)
Number of subjects: 1289

Group type: COMPARATOR
Intervention: Active-reference preparations and placebos
Number of subjects: 1289
Study: 3093661

Group type: EXPERIMENTAL
Intervention: Intact milk formula
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Lactose-free preparation
Number of subjects: 20
Study: 31393746

Group type: EXPERIMENTAL
Intervention: CT-guided thermal ablation with an EM navigation system
Number of subjects: 40

Group type: COMPARATOR
Intervention: Conventional CT-guided thermal ablation
Number of subjects: 40
Study: 30287661

Group type: EXPERIMENTAL
Intervention: 1-year financial support program for education
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 28514624

Group type: EXPERIMENTAL
Intervention: Evacetrapib (130 mg daily)
Number of subjects: 12092

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12092

Group type: EXPERIMENTAL
Intervention: Evacetrapib
Number of subjects: 12092
Study: 26143106

Group type: EXPERIMENTAL
Intervention: Pemetrexed plus carboplatin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Pemetrexed alone
Number of subjects: 0
Study: 23135693

Group type: EXPERIMENTAL
Intervention: 10 mg tropisetron alone (T)
Number of subjects: 224

Group type: EXPERIMENTAL
Intervention: 10 mg tropisetron and 8 mg dexamethasone (TD)
Number of subjects: 224

Group type: EXPERIMENTAL
Intervention: 10 mg tropisetron and 40 mg methylprednisolone (TM)
Number of subjects: 224
Study: 21542721

Group type: EXPERIMENTAL
Intervention: Vitamin D3 (300,000 IU/month intramuscular injection for 6 months)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Placebo (intramuscular injection for 6 months)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Vitamin D3
Number of subjects: 62
Study: 18498678

Group type: EXPERIMENTAL
Intervention: Fluticasone furoate 200 mcg once-daily for 8 days
Number of subjects: 59

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 59
Study: 17205817

Group type: EXPERIMENTAL
Intervention: Three-step sequential method (TSSM) plus inhalation of Pulmicort Turbuhaler 200 microg, twice a day
Number of subjects: 40

Group type: COMPARATOR
Intervention: Pulmicort Turbuhaler alone
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Both groups (TSSM and control)
Number of subjects: 40
Study: 15058750

Group type: EXPERIMENTAL
Intervention: Brimonidine-Purite 0.15%
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Brimonidine-Purite 0.15% (first)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Brimonidine tartrate 0.2% (first)
Number of subjects: 20
Study: 10966540

Group type: EXPERIMENTAL
Intervention: Electric cardioversion (n = 11)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Pharmacologic cardioversion (n = 24)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Control group (n = 70)
Number of subjects: 35
Study: 8694043

Group type: EXPERIMENTAL
Intervention: Misoprostol every 3 hours (maximum of 8 doses)
Number of subjects: 522

Group type: COMPARATOR
Intervention: Misoprostol every 6 hours (maximum of 4 doses)
Number of subjects: 522

Group type: COMPARATOR
Intervention: Misoprostol every 6 hours
Number of subjects: 522

Group type: EXPERIMENTAL
Intervention: Misoprostol every 3 hours
Number of subjects: 522

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 522
Study: 1713484

Group type: EXPERIMENTAL
Intervention: Arginine aspartate (AA)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study: 6815664

Group type: EXPERIMENTAL
Intervention: Lithium carbonate ('Priadel')
Number of subjects: 5

Group type: COMPARATOR
Intervention: Lithium citrate ('Litarex')
Number of subjects: 5
Study: 31725942

Group type: EXPERIMENTAL
Intervention: Vortioxetine 10 mg
Number of subjects: 489

Group type: EXPERIMENTAL
Intervention: Vortioxetine 20 mg
Number of subjects: 489

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 489
Study: 31050355

Group type: EXPERIMENTAL
Intervention: Obinutuzumab plus bendamustine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Obinutuzumab
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 27696720

Group type: COMPARATOR
Intervention: FeFol (iron and folic acid tablet)
Number of subjects: 620

Group type: EXPERIMENTAL
Intervention: MMN (multiple-micronutrients tablet)
Number of subjects: 620

Group type: EXPERIMENTAL
Intervention: PE (protein-energy lipid-based nutritional supplement)
Number of subjects: 620

Group type: EXPERIMENTAL
Intervention: PE + MMN (protein-energy + multiple-micronutrients lipid-based nutritional supplement)
Number of subjects: 620

Group type: EXPERIMENTAL
Intervention: PE + MMN
Number of subjects: 620
Study: 25837705

Group type: EXPERIMENTAL
Intervention: Testosterone administration (2 mg/kg testosterone enanthate monthly for two months before surgery)
Number of subjects: 182
Study: 23389112

Group type: EXPERIMENTAL
Intervention: High fiber (HF) diet
Number of subjects: 25

Group type: COMPARATOR
Intervention: Low fiber (LF) diet
Number of subjects: 25
Study: 22941976

Group type: EXPERIMENTAL
Intervention: Asthma risk registers intervention with electronic alerts and practice-based training
Number of subjects: 911

Group type: COMPARATOR
Intervention: Control group (routine care)
Number of subjects: 911
Study: 20023343

Group type: EXPERIMENTAL
Intervention: Muscle energy technique (MET) group, n=15
Number of subjects: 30

Group type: COMPARATOR
Intervention: Static stretch group (controls), n=15
Number of subjects: 30
Study: 17540191

Group type: EXPERIMENTAL
Intervention: Nurse-administered tailored behavioral intervention
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: Nurse-administered medication management
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: Combination of tailored behavioral intervention and medication management
Number of subjects: 600

Group type: COMPARATOR
Intervention: Control group (usual care)
Number of subjects: 600
Study: 15510946

Group type: EXPERIMENTAL
Intervention: Delayed cord clamping (after the cord stopped pulsating)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Early cord clamping (within 10s after delivery)
Number of subjects: 104
Study: 11451215

Group type: EXPERIMENTAL
Intervention: Olmesartan medoxomil (OM) 10 mg once daily
Number of subjects: 0

Group type: COMPARATOR
Intervention: Atenolol 50 mg once daily
Number of subjects: 0
Study: 9649062

Group type: EXPERIMENTAL
Intervention: ET0-sterilized low-flux polysulphone membranes (F6)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Steam-sterilized polysulphone membranes (F6-HPS)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Switching back to ETO-sterilized membranes (F6)
Number of subjects: 6
Study: 7747848

Group type: EXPERIMENTAL
Intervention: Propofol (median dose 3.1 mg.kg‐1)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Thiopentone (median dose 6.0 mg.kg‐1)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Intralipid 10% 0.3 ml.kg‐1
Number of subjects: 23
Study: 2204553

Group type: EXPERIMENTAL
Intervention: LH-kit cycles (1 insemination)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Non-LH method cycles (2 alternate day inseminations)
Number of subjects: 60
Study: 299451

Group type: EXPERIMENTAL
Intervention: butorphanol/acetaminophen
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: oxycodone/acetaminophen
Number of subjects: 104

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 104
Study: 31594200

Group type: EXPERIMENTAL
Intervention: High Intensity Laser Therapy (HILT)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Transcutaneous Electrical Nerve Stimulation (TENS)
Number of subjects: 40
Study: 31509332

Group type: EXPERIMENTAL
Intervention: Mother-Child Education Program (MOCEP)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Implementation evaluation
Number of subjects: 0
Study: 28376743

Group type: EXPERIMENTAL
Intervention: 500 μg FLU-v in saline (arm 1)
Number of subjects: 222

Group type: EXPERIMENTAL
Intervention: Emulsified 500 μg FLU-v in Montanide ISA-51 and WFI followed by one saline dose (arm 2)
Number of subjects: 222

Group type: EXPERIMENTAL
Intervention: Montanide ISA-51 and WFI emulsion followed by one saline dose (arm 4)
Number of subjects: 222

Group type: COMPARATOR
Intervention: Two saline doses (arm 3)
Number of subjects: 222
Study: 25983095

Group type: EXPERIMENTAL
Intervention: CCRT with docetaxel and capecitabine
Number of subjects: 81

Group type: COMPARATOR
Intervention: Chemotherapy with docetaxel and capecitabine
Number of subjects: 81
Study: 24417600

Group type: EXPERIMENTAL
Intervention: Multisystemic Therapy (MST)
Number of subjects: 129

Group type: COMPARATOR
Intervention: Individual Therapy (IT)
Number of subjects: 129
Study: 22137191

Group type: EXPERIMENTAL
Intervention: PermaNet 2.0 (Vestergaard‐Frandsen, Denmark)
Number of subjects: 0
Study: 20631375

Group type: EXPERIMENTAL
Intervention: Romiplostim 500 μg
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Romiplostim 750 μg
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 17952697

Group type: EXPERIMENTAL
Intervention: Water exercise once-weekly for 24 weeks
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Water exercise twice-weekly for 24 weeks
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (no specific intervention details provided)
Number of subjects: 30
Study: 15602503

Group type: EXPERIMENTAL
Intervention: Nalbuphine (5 mg/70 kg, intravenous)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nalbuphine+cocaine (combination)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cocaine (0.2 mg/kg, intravenous)
Number of subjects: 0
Study: 12670118

Group type: EXPERIMENTAL
Intervention: HBO2 therapy
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: HBO2 + Scaling
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Scaling
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control
Number of subjects: 24
Study: 10611552

Group type: EXPERIMENTAL
Intervention: Fresh egg and cow's milk powder
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 7700752

Group type: EXPERIMENTAL
Intervention: DTP and PRP-T in one injection (Group 1)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: DTP and PRP-T separately (Group 2)
Number of subjects: 150

Group type: COMPARATOR
Intervention: DTP and HbOC separately (Group 3)
Number of subjects: 150
Study: 2505632

Group type: EXPERIMENTAL
Intervention: Flumazenil 1.0 mg
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Flumazenil 4 mg
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study: 1107233

Group type: EXPERIMENTAL
Intervention: Fraction A
Number of subjects: 131

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 131
Study: 31415571

Group type: EXPERIMENTAL
Intervention: Invitation to commit to becoming better prepared for floods
Number of subjects: 774

Group type: COMPARATOR
Intervention: No commitment invitation (control group)
Number of subjects: 774
Study: 29187413

Group type: EXPERIMENTAL
Intervention: Sevoflurane-based inhalational anaesthesia
Number of subjects: 1200

Group type: COMPARATOR
Intervention: Propofol-based intravenous anaesthesia
Number of subjects: 1200
Study: 24824770

Group type: EXPERIMENTAL
Intervention: Methylphenidate treatment + 6‐wk exercise (sports‐ADHD)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Methylphenidate treatment + 6‐wk education (edu‐ADHD)
Number of subjects: 35
Study: 23463297

Group type: EXPERIMENTAL
Intervention: St. John's Wort (SJW) 300 mg × 3/day for 2 weeks after PCI
Number of subjects: 23

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: St. John's Wort (SJW)
Number of subjects: 23
Study: 21228120

Group type: EXPERIMENTAL
Intervention: Air-particle abrasion (APA) with 25 μm Al(2)O(3)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Silica coating with 30 μm Al(2)O(3) particles modified by silica
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Silica coating
Number of subjects: 60
Study: 20078381

Group type: EXPERIMENTAL
Intervention: 0.075% retinol cream
Number of subjects: 57

Group type: COMPARATOR
Intervention: Vehicle (control)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: 0.04% retinol cream
Number of subjects: 57
Study: 16278692

Group type: EXPERIMENTAL
Intervention: Pomegranate juice (PJ) supplementation (400 ml daily for 5 weeks)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo (synthetic orange‐flavoured drink, 400 ml daily for 5 weeks)
Number of subjects: 30
Study: 15519498

Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study: 11481130

Group type: EXPERIMENTAL
Intervention: Desipramine-Alone
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Cognitive/Behavioral Therapy-Alone (CBT)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Combined (Desipramine + CBT)
Number of subjects: 102
Study: 9233238

Group type: EXPERIMENTAL
Intervention: Topical application of essential fatty acids (EFA) - 20 ml solution A (1.6 gr EFA with linoleic acid, 112 UI vitamin A, 5 UI Vitamin E) applied every 8 hours for 21 days
Number of subjects: 86

Group type: COMPARATOR
Intervention: Topical application of mineral oil - 20 ml solution B (1.6 gr mineral oil, 112 UI Vitamin A, 5 UI Vitamin E) applied every 8 hours for 21 days
Number of subjects: 86
Study: 7596115

Group type: EXPERIMENTAL
Intervention: Signal uncertainty (randomly at 501 or 2818 Hz)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Masker uncertainty (random-frequency, random-level tonal distracters)
Number of subjects: 0
Study: 2590807

Group type: EXPERIMENTAL
Intervention: Amantadine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 5320590

Group type: EXPERIMENTAL
Intervention: Chronic chlorpromazine (CPZ) administration
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 0
Study: 30753377

Group type: EXPERIMENTAL
Intervention: Combination of azathioprine with adalimumab
Number of subjects: 0

Group type: COMPARATOR
Intervention: Adalimumab monotherapy
Number of subjects: 0
Study: 28650784

Group type: EXPERIMENTAL
Intervention: Papacarie Duo
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Carie Care
Number of subjects: 20
Study: 25887060

Group type: EXPERIMENTAL
Intervention: Mental imagery
Number of subjects: 30
Study: 23128963

Group type: EXPERIMENTAL
Intervention: Oral ibuprofen 10 mg/kg within 12‐24 h after birth followed by 5 mg/kg at 24 and 48 h
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group (no ibuprofen treatment)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Oral ibuprofen
Number of subjects: 36
Study: 21778084

Group type: EXPERIMENTAL
Intervention: ProTaper files with 30-gauge conventional dental needle
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: RaCe files with 30-gauge conventional dental needle
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: ProTaper files with side-vented irrigation needle
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: RaCe files with side-vented irrigation needle
Number of subjects: 40
Study: 19034493

Group type: EXPERIMENTAL
Intervention: PCT-guided group
Number of subjects: 27

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 27
Study: 16965418

Group type: EXPERIMENTAL
Intervention: Corticosteroids (four different types)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo (cream base formulation)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: High-frequency ultrasound
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Profilometry
Number of subjects: 20
Study: 12723850

Group type: EXPERIMENTAL
Intervention: Atypical antipsychotic medications
Number of subjects: 0
Study: 11248173

Group type: EXPERIMENTAL
Intervention: Preoperative mortality risk estimation formula
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: Immediate postoperative mortality risk estimation formula
Number of subjects: 134
Study: 9240877

Group type: EXPERIMENTAL
Intervention: L-thyroxine (LT4) replacement therapy
Number of subjects: 44
Study: 7506175

Group type: EXPERIMENTAL
Intervention: Nimesulide (50mg granules)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Nimesulide (5 mg/kg/day)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Paracetamol (26 mg/kg/day)
Number of subjects: 100
Study: 2896967

Group type: EXPERIMENTAL
Intervention: Cimetidine
Number of subjects: 562

Group type: EXPERIMENTAL
Intervention: Ranitidine
Number of subjects: 562

Group type: EXPERIMENTAL
Intervention: Pirenzepine
Number of subjects: 562

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 562

Group type: EXPERIMENTAL
Intervention: Tripotassium dicitrato-bismuthate
Number of subjects: 562

Group type: EXPERIMENTAL
Intervention: Smokers
Number of subjects: 562

Group type: EXPERIMENTAL
Intervention: Non-smokers
Number of subjects: 562